ID MV522/MRP AC CVCL_0E38 DR ATCC; CRL-2521 DR BioSample; SAMN03471605 DR cancercelllines; CVCL_0E38 DR Wikidata; Q54907111 RX PubMed=10831281; CC Problematic cell line: Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line). CC Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:51; ABCC1. CC Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. CC Discontinued: ATCC; CRL-2521; true. CC Derived from site: In situ; Colon; UBERON=UBERON_0001155. ST Source(s): ATCC=CRL-2521 ST Amelogenin: X ST CSF1PO: 12 ST D13S317: 11,12 ST D16S539: 11,12 ST D5S818: 11,12 ST D7S820: 10 ST TH01: 6 ST TPOX: 8,9 ST vWA: 17,19 DI NCIt; C4349; Colon adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_7204 ! MV-522 SX Female AG 44Y CA Cancer cell line DT Created: 10-04-15; Last updated: 14-08-25; Version: 24 // RX PubMed=10831281; DOI=10.1097/00001813-200003000-00010; RA Kelner, Michael J. RA McMorris, Trevor C. RA Estes, Leita A. RA Oval, Michelle Y. RA Rojas, Rafael J. RA Lynn, Joshua R. RA Lanham, Kevin A. RA Samson, Kyra M. RT "Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung RT carcinoma xenograft."; RL Anticancer Drugs 11:217-224(2000). //